학술논문

Phase 2 of extracellular RNA communication consortium charts next-generation approaches for extracellular RNA research
Document Type
article
Author
Mateescu, BogdanJones, Jennifer CAlexander, Roger PAlsop, EricAn, Ji YeongAsghari, MohammadBoomgarden, AlexBouchareychas, LauraCayota, AlfonsoChang, Hsueh-ChiaCharest, AlChiu, Daniel TCoffey, Robert JDas, SaumyaDe Hoff, PeterdeMello, AndrewD’Souza-Schorey, CrislynElashoff, DavidEliato, Kiarash RFranklin, Jeffrey LGalas, David JGerstein, Mark BGhiran, Ionita HGo, David BGould, StephenGrogan, Tristan RHigginbotham, James NHladik, FlorianHuang, Tony JunHuo, XiaoyeHutchins, ElizabethJeppesen, Dennis KJovanovic-Talisman, TijanaKim, Betty YSKim, SungKim, Kyoung-MeeKim, YongKitchen, Robert RKnouse, VaughanLaPlante, Emily LLebrilla, Carlito BLee, L JamesLennon, Kathleen MLi, GuopingLi, FengLi, TieyiLiu, TaoLiu, ZiruiMaddox, Adam LMcCarthy, KyleMeechoovet, BessieManiya, NalinMeng, YingchaoMilosavljevic, AleksandarMin, Byoung-HoonMorey, AmberNg, MartinNolan, JohnDe Oliveira, Getulio PPaulaitis, Michael EPhu, Tuan AnhRaffai, Robert LReátegui, EduardoRoth, Matthew ERoutenberg, David ARozowsky, JoelRufo, JosephSenapati, SatyajyotiShachar, SigalSharma, HimaniSood, Anil KStavrakis, StavrosStürchler, AlessandraTewari, MuneeshTosar, Juan PTucker-Schwartz, Alexander KTurchinovich, AndreyValkov, NedyalkaVan Keuren-Jensen, KendallVickers, Kasey CVojtech, LuciaVreeland, Wyatt NWang, CemingWang, KaiWang, ZeYuWelsh, Joshua AWitwer, Kenneth WWong, David TWXia, JianpingXie, Ya-HongYang, KaichunZaborowski, Mikołaj PZhang, ChenguangZhang, QinZivkovic, Angela MLaurent, Louise C
Source
iScience. 25(8)
Subject
Biological Sciences
Biomedical and Clinical Sciences
Genetics
Human Genome
Biochemistry
Biological sciences
Cell biology
Molecular biology
Language
Abstract
The extracellular RNA communication consortium (ERCC) is an NIH-funded program aiming to promote the development of new technologies, resources, and knowledge about exRNAs and their carriers. After Phase 1 (2013-2018), Phase 2 of the program (ERCC2, 2019-2023) aims to fill critical gaps in knowledge and technology to enable rigorous and reproducible methods for separation and characterization of both bulk populations of exRNA carriers and single EVs. ERCC2 investigators are also developing new bioinformatic pipelines to promote data integration through the exRNA atlas database. ERCC2 has established several Working Groups (Resource Sharing, Reagent Development, Data Analysis and Coordination, Technology Development, nomenclature, and Scientific Outreach) to promote collaboration between ERCC2 members and the broader scientific community. We expect that ERCC2's current and future achievements will significantly improve our understanding of exRNA biology and the development of accurate and efficient exRNA-based diagnostic, prognostic, and theranostic biomarker assays.